Coloplast ASCLPBF 72 Interest Coverage is 9.68 as of Mar. 2026, which is 96% below its 10-year median of 224.67. GuruFocus rates CLPBF with a GF Score™ of 72/100 and a GF Value™ of $126.91 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 468 Medical Devices & Instruments companies, Coloplast AS ranks worse than 66.88% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Coloplast AS's
Operating Income
for the
three
months ended in Mar. 2026 was $282 Mil. Coloplast AS's Interest Expense for the
three
months ended in Mar. 2026 was $-29 Mil.
Coloplast AS's interest coverage for the quarter that ended in Mar. 2026 was 9.68.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Coloplast AS's Interest Coverage or its related term are showing as below:
CLPBF'
s Interest Coverage Range Over the Past 10 Years
Min: 7.29 Med: 224.67 Max: 926
Current: 7.29
CLPBF's Interest Coverage is ranked worse than 66.88% of 468
companies
in the Medical Devices & Instruments industry
Industry Median: 15.71
vs CLPBF: 7.29
Coloplast AS (OTCPK:CLPBF) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Coloplast AS Interest Coverage Related Terms
Coloplast AS Interest Coverage Historical Data
* Premium members only.
The historical data trend for Coloplast AS's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
CLPBF vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Coloplast AS's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coloplast AS Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Coloplast AS's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coloplast AS (CLPBF) has a Interest Coverage of 9.68 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Coloplast AS and its competitors. This is 96% below median its historical median of 224.67. Over the past decade, Coloplast AS's Interest Coverage has ranged from 7.29 to 926.00. According to the industry distribution chart, Coloplast AS ranks #313 out of 468 companies in the Medical Devices & Instruments industry, placing it in the top 66.9%.
Is Coloplast AS's Interest Coverage too high?
Coloplast AS's current Interest Coverage of 9.68 is 96% below median its 10-year median of 224.67. Over the past 10 years, this metric has ranged from a low of 7.29 to a high of 926.00. The Medical Devices & Instruments industry median Interest Coverage is 15.71. Coloplast AS's value of 9.68 is 38.4% below this industry median. Based on the distribution chart, Coloplast AS ranks #313 out of 468 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Coloplast AS has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coloplast AS ranks #313 out of 468 companies for Interest Coverage. This places Coloplast AS in the lower half of its industry. The industry median Interest Coverage is 15.71. Coloplast AS's value of 9.68 is 38.4% below this benchmark. Historically, Coloplast AS's own Interest Coverage has ranged from 7.29 to 926.00 over the past decade. While the company's 10-year median is 224.67 vs. the industry median of 15.71, Coloplast AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.71, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coloplast AS's current Interest Coverage of 9.68 is 38.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Coloplast AS and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coloplast AS's current Interest Coverage is 9.68, which is 96% below median its own 10-year median of 224.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (CLPBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $126.91, compared to a current price of $57.41 — trading 54.8% below its estimated fair value. The current Interest Coverage is 9.68, which is 96% below median its 10-year median of 224.67 and 38.4% below the Medical Devices & Instruments industry median of 15.71. Coloplast AS's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Coloplast AS (CLPBF), the current Interest Coverage is 9.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coloplast AS (CLPBF) Overvalued in 2026?
Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued.
The current stock price of $57.41 is trading 54.8% below its estimated GF Value™ of $126.91.
GuruFocus considers Coloplast AS to be Significantly Undervalued.
Key valuation signals for CLPBF:
Interest Coverage: 9.68 (96% below median its 10-year median of 224.67)
GF Value™: $126.91 vs. price of $57.41 (54.8% below fair value)
Industry Position: 38.4% below the Medical Devices & Instruments median (#313 of 468)
No single metric tells the full story. See the CLPBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
72GF Score
Get the complete analysis for CLPBF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLPBF has been successfully added to your 
